 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
Biotech Firm to Test AIDS VaccineJune 12, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Targeted Genetics Corp., an unprofitable developer of gene-therapy drugs, said it will begin human tests of an AIDS vaccine
this year after seeing positive results in animal studies. The
vaccine, tgAACO9, prompted an immune response in rabbits, the
company said in a statement. Safety testing in humans will begin
in the second half of 2003, according to the Seattle-based
company. Earlier this year, Targeted Genetics reduced its work
force and cut some research programs to conserve cash for
developing its AIDS vaccine and cystic fibrosis and arthritis
therapies.
Back to other CDC news for June 12, 2003 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Seattle Post-Intelligencer 06.07.03; Bloomberg News This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
E-Mail
Printable Single-Page
Glossary
Share
